Forodesine

BioCryst Reports New Data from Its Phase 2 Forodesine Study in Patients with Chronic Lymphocytic Leukemia at the 52nd Annual American Society of Hematology Meeting
Yahoo/BusinessWire
Sat, 12/4/10 - 12:04 pm
Biocryst
Forodesine
leukemia
chronic lymphocytic leukemia